137 related articles for article (PubMed ID: 1698579)
1. Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.
Izquierdo M; Balboa MA; Fernández-Rañada JM; Figuera A; Torres A; Iriondo A; López-Botet M
Clin Exp Immunol; 1990 Oct; 82(1):145-50. PubMed ID: 1698579
[TBL] [Abstract][Full Text] [Related]
2. Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantation.
López-Botet M; De Landazuri MO; Izquierdo M; Ramirez A; Cámara R; Fernández-Rañada J
Eur J Immunol; 1987 Aug; 17(8):1167-74. PubMed ID: 3113980
[TBL] [Abstract][Full Text] [Related]
3. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection.
Dolstra H; Preijers F; Van de Wiel-van Kemenade E; Schattenberg A; Galama J; de Witte T
Br J Haematol; 1995 Jun; 90(2):300-7. PubMed ID: 7540855
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.
Welte K; Keever CA; Levick J; Bonilla MA; Merluzzi VJ; Mertelsmann R; Evans R; O'Reilly RJ
Blood; 1987 Nov; 70(5):1595-603. PubMed ID: 3311208
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine production by T-cell clones after human bone marrow transplantation.
Velardi A; Varese P; Terenzi A; Dembech C; Albi N; Grossi CE; Moretta L; Martelli MF; Grignani F; Mingari MC
Blood; 1989 Oct; 74(5):1665-72. PubMed ID: 2506949
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.
Katsanis E; Anderson PM; Filipovich AH; Hasz DE; Rich ML; Loeffler CM; Ochoa AC; Weisdorf DJ
Blood; 1991 Sep; 78(5):1286-91. PubMed ID: 1831682
[TBL] [Abstract][Full Text] [Related]
8. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT.
Mollet L; Fautrel B; Leblond V; Bergeron F; Merle-Béral H; Baumelou E; Hubert P; Debré P; Autran B
Leukemia; 1999 Feb; 13(2):230-40. PubMed ID: 10025897
[TBL] [Abstract][Full Text] [Related]
9. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
[TBL] [Abstract][Full Text] [Related]
10. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
11. Abnormally expanded CD8+/Leu-7+ lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-lymphocytes.
Leroy E; Madariaga L; Ben Aribia M; Mishal Z; Theodorou I; Rochant H; Vernant JP; Senik A
Exp Hematol; 1990 Aug; 18(7):770-4. PubMed ID: 1696205
[TBL] [Abstract][Full Text] [Related]
12. Analysis of different protein kinase C-dependent events in T cells from allogeneic bone marrow transplantation recipients.
Balboa MA; Izquierdo M; Sánchez-Madrid F; Fernández-Rañada JM; López-Botet M
Clin Exp Immunol; 1992 Mar; 87(3):478-84. PubMed ID: 1544233
[TBL] [Abstract][Full Text] [Related]
13. The immunodeficiency of bone marrow-transplanted patients. II. CD8-related suppression by patient lymphocytes of the response of donor lymphocytes to mitogens, antigens, and allogeneic cells.
Odum N; Hofmann B; Jacobsen N; Langhoff E; Møller J; Platz P; Ryder LP; Svejgaard A
Scand J Immunol; 1987 Sep; 26(3):247-53. PubMed ID: 2958929
[TBL] [Abstract][Full Text] [Related]
14. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
[TBL] [Abstract][Full Text] [Related]
15. T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2.
Cayeux S; Meuer S; Pezzutto A; Körbling M; Haas R; Schulz R; Dörken B
Blood; 1989 Nov; 74(6):2270-7. PubMed ID: 2572284
[TBL] [Abstract][Full Text] [Related]
16. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.
Mollet L; Sadat-Sowti B; Duntze J; Leblond V; Bergeron F; Calvez V; Katlama C; Debré P; Autran B
Int Immunol; 1998 Mar; 10(3):311-23. PubMed ID: 9576619
[TBL] [Abstract][Full Text] [Related]
17. CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.
Reipert B; Scheuch C; Lukowsky A; Reinke P; Fietze E; Döcke WD; Staffa G; Czerlinksi S; Hetzer R; Volk HD
Clin Exp Immunol; 1992 Jul; 89(1):143-7. PubMed ID: 1378363
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
Klingemann HG; Kohn FR; Phillips GL
Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T-cell-depleted bone marrow transplant recipients.
Rowbottom AW; Garland RJ; Lepper MW; Kaneria SS; Goulden NJ; Oakhill A; Steward CG
Br J Haematol; 2000 Aug; 110(2):315-21. PubMed ID: 10971387
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
